IMS sets out top 10 strategic issues facing pharma industry
IMS has identified 10 critical developments in 2007 that could have a fundamental effect on the operating environment for pharmaceutical companies in the coming years.
Archives for May 13, 2008
ORF Genetics' $1m geothermal plant
The opening of ORF Genetics' $1m production site for recombinant proteins in Grindavik, Iceland, is yet another groundbreaking move by this year's winner of the Icelandic Centre for Research's innovation award.